Role of Gi proteins in the antidepressant-like effect of amitriptyline and clomipramine

Neuropsychopharmacology

Volumn 27, Issue 4, 2002, Pages 554-564

  Galeotti, Nicoletta ^a   Bartolini, Alessandro ^a   Ghelardini, Carla ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Dept of Pharmacology ^*  (Italy)

Author keywords

Amitriptyline; Antisense oligodeoxyribonucleotides; Clomipramine; Gi proteins; Pertussis toxin; Tricyclic antidepressants

Indexed keywords

AMITRIPTYLINE; ANTISENSE OLIGODEOXYNUCLEOTIDE; CLOMIPRAMINE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; PERTUSSIS TOXIN; PROTEIN SUBUNIT;

ALPHA CHAIN; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG MECHANISM; FORCED SWIMMING TEST; MALE; MOBILIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION; TIME;

AMITRIPTYLINE; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BRAIN; BRAIN CHEMISTRY; CLOMIPRAMINE; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GTP-BINDING PROTEIN ALPHA SUBUNIT, GI2; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HETEROTRIMERIC GTP-BINDING PROTEINS; MALE; MICE; MOTOR ACTIVITY; MOTOR SKILLS; MUSCULOSKELETAL EQUILIBRIUM; OLIGONUCLEOTIDES, ANTISENSE; PERTUSSIS TOXIN; PROTO-ONCOGENE PROTEINS;

EID: 0036790867     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(02)00340-8     Document Type: Article

References (46)

1. Birnbaumer L. G proteins in signal transduction. Annu Rev Pharmacol Toxicol. 30:1990;675-705.
2. Borsini F., Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology (Berl). 94:1988;147-160.
3. Bourin M., Colombel M.C., Maligne M., Bradwejn J. Clonidine as a sensitizing agent in the forced swimming test for revealing antidepressant activity. J Psychiatr Neurosci. 16:1991;199-203.
4. Capaccioli S., Di Pasquale G., Mini E., Mazzei T., Quattrone A. Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum. Biochem Biophys Res Comm. 107:1993;818-825.
5. Chen J., Rasenick M.M. Chronic antidepressant treatment facilitates G protein activation without altering G protein content. J Pharmacol Exp Ther. 275:1995;509-517.
6. Detke M.J., Lucki I. Detection of serotoninergic and norad- renergic antidepressants in the rat forced swimming test. the effects of water depth Behav Brain Res. 73:1996;43-46.
7. Donati R.J., Thukral C., Rasenick M.M. Chronic treatment of C6 glioma cells with antidepressant drugs results in a redistribution of Gsα Mol Pharmacol. 59:2001;1426-1432.
8. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Arch Gen Psychiatr. 54:1997;597-606.
9. Dwivedi Y., Pandey G.N. Effects of subchronic administration of antidepressants and anxiolytics on levels of the alpha subunits of G proteins in the rat brain. J Neural Transm. 104:1997;747-760.
10. Emamghoreishi M., Warsh J.J., Sibony D., Li P.P. Lack of effect of chronic antidepressant treatment on Gs and Gi alpha-subunit protein and mRNA levels in the rat cerebral cortex. Neuropsychopharmacology. 15:1996;281-287.
11. Garcia-Sevilla J.A., Escriba P.V., Ozaita A., La Harpe R., Walzer C., Eytan A., Guimon J. Up-regulation of immunolabeled alpha2A-adrenoceptors, Gi coupling proteins, and regulatory receptor kinases in the prefrontal cortex of depressed suicides. J Neurochem. 72:1999;282-291.
12. i2 subunit and down-regulation by antidepressant drug treatment Biol Psychiatry. 42:1997;704-712.
13. Haley T.J., McCormick W.G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol Chemother. 12:1957;12-15.
14. Henringer G.R., Charney D.S. Mechanism of action of antidepressant treatments. Implications for the etiology and treatment of depressive disorders Meltzer H.Y. Psychopharmacology. The Third Generation of Progress:1987;535-544 Raven Press, New York.
15. Hille B. Modulation of ion-channel function by G-protein-coupled receptors. Trends Neurosci. 17:1994;531-536.
16. Holtz G.G., Rane S.G., Dunlap K. GTP-binding proteins mediate transmitter inhibition of voltage-dependent calcium channels. Nature. 319:1986;670-672.
17. Kamada H., Saito T., Hatta S., Toki S., Ozawa H., Watanabe M., Takahata N. Alterations of tubulin function caused by chronic antidepressant treatment in rat brain. Cell Mol Neurobiol. 19:1999;109-117.
18. Karege F., Bovier P., Rudolph W., Gaillard J.M. Platelet phosphoinositide signaling system. an overstimulated pathway in depression Biol Psychiatry. 39:1996;697-702.
19. Karege F., Bovier P., Stepanian R., Malafosse A. The effect of clinical outcome on platelet G proteins of major depressed patients. Eur Neuropsychopharmacol. 8:1998;89-94.
20. Katada T., Ui M. Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP ribosilation of a membrane protein. Proc Natl Acad Sci USA. 79:1982;3129-3133.
21. Kleuss C., Hescheler J., Ewel C., Rosenthal W., Schultz G., Wittig B. Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents. Nature. 353:1991;43-48.
22. Lason W., Przewlocki R. The effect of chronic treatment with imipramine on the G proteins mRNA level in the rat hippocampus - an interaction with a calcium channel antagonist. Pol J Pharmacol. 45:1993;219-226.
23. Lesch K.P., Manji H.K. Signal-transducing G proteins and antidepressant drugs. evidence for modulation of alpha subunit gene expression in rat brain Biol Psychiatry. 32:1992;549-579.
24. Lesch K.P., Aulakh C.S., Tolliver T.J., Hill J.L., Murphy D.L. Regulation of G proteins by chronic antidepressant drug treatment in rat brain. tricyclics but not clorgyline increase Go alpha subunits Eur J Pharmacol. 207:1991;361-364.
25. Li P.P., Young L.T., Tam Y.K., Sibony D., Warsh J.J. Effects of chronic lithium and carbamazepine treatment on G-protein subunit expression in rat cerebral cortex. Biol Psychiatry. 34:1993;162-170.
26. Mazzola-Pomietto P., Azorin J.M., Tramoni V., Jeanningros R. Relation between lymphocyte beta-adrenergic responsivity and the severity of depressive disorders. Biol Psychiatry. 35:1994;920-925.
27. Menkes D.B., Rasenick M.M., Wheeler M.A., Bitensky M.W. Guanosine triphosphate activation of brain adenylate cyclase. enhancement by long-term antidepressant treatment Science. 219:1983;65-67.
28. Mishra R., Janowsky A., Sulser F. Action of mianserin and zimelidine on the norepinephrine receptor coupled adenylate cyclase system in brain. subsensitivity without reduction in β-adrenergic receptor binding Neuropharmacology. 19:1980;983-987.
29. 1A receptor-mediated effects of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry. 17:1993;1-19.
30. Nibuya M., Nestler E.J., Duman R.S. Chronic antidepressant administration increases the expression of cAMP respons element binding protein (CREB) in rat hippocampus. J Neurosci. 16:1996;2365-2372.
31. Okada F., Tokumitsu Y., Ui M. Desensitization of β-adrenergic receptor-coupled adenylate cyclase in cerebral cortex after in vivo treatment of rats with desipramine. J Neurochem. 47:1986;454-459.
32. Ozawa H., Rasenick M.M. Coupling of the stimulatory GTP-binding protein Gs to rat synaptic membranes adenylate cyclase is enhanced subsequent to chronic antidepressant treatment. Mol Pharmacol. 36:1989;803-808.
33. Porsolt R.D., Anton G., Blavet N., Jalfre M. Behavioural despair in rats. a new model sensitive to antidepressant treatments Eur J Pharmacol. 47:1978;379-391.
34. Porsolt R.D., Bertin A., Jalfre M. Behavioural despair in mice. A primary screening test for antidepressants Arch Int Pharmacodyn. 229:1977;327-336.
35. 1A receptors. reductions in neuroendocrine responses to 8-OH-DPAT and in levels of Gz and Gi proteins J Pharmacol Exp Ther. 288:1999;98-106.
36. Raffa R.B., Martinez R.P., Connelly C.D. G-protein antisense oligodeoxynucleotides and μ-opioid supraspinal antinociception. Eur J Pharmacol. 258:1994;R5-R7.
37. Sanchez-Blazquez P., Garzon J. Delta opioid subtypes activates inositol-signaling pathways in the production of antinociception. J Pharmacol Exp Ther. 285:1998;820-827.
38. Sanchez-Blazquez P., Garcia-Espana A., Garzon J. In vivo injection of oligodeoxynucleotides to Gα subunits and supraspinal evoked by mu and delta opioid agonists. J Pharmacol Exp Ther. 275:1995;1590-1596.
39. Schildkraut J.J. The catecholamine hypothesis of affective disorders. a review of supporting evidence Am J Psychiatry. 122:1965;509-522.
40. Simon M.I., Strathman M.P., Gautman N. Diversity of G proteins in signal transduction. Science. 252:1991;802-808.
41. Sprang S.R. G-protein mechanisms. insights from structural analysis Annu Rev Biochem. 66:1997;639-668.
42. Thome J., Sakai N., Shin K., Steffen C., Zhang Y., Impey S., Storm D., Duman R.S. cAMP response element-mediated gene transcription is up-regulated by chronic antidepressant treatment. J Neurosci. 20:2000;4030-4036.
43. Vaught J., Pelley K., Costa L.G., Sether P., Enna S.J. A comparison of the antinociceptive responses to GABA-receptor agonists THIP and baclofen. Neuropharmacology. 24:1985;211-216.
44. Willner P. The validity of animal models for depression. Psychopharmacology (Berl). 83:1984;1-16.
45. Yamamoto H., Tomita U., Mikuni M., Kobayashi I., Kagaya A., Katada T., Ui M., Takahashi K. Direct activation of purified Go-type GTP binding protein by tricyclic antidepressants. Neurosci Lett. 139:1992;194-196.
46. Yamaoka K., Nanba T., Nomura S. Direct influence of antidepressants on GTP binding protein of adenylate cyclase in cell membranes of the cerebral cortex of rats. J Neural Transm. 71:1988;165-175.